Stock screenerAll disclosures →
EDGAR →
RYTM
Conviction 92HealthcareScan · Mon, Aug 10, 2026RYTM$115.52-0.10%
ResistanceSupportVol 14Insider sellVol MA14 863.41K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price115.52
Change-0.10%
Gap-1.22%
Rel volume2.91×
Avg volume781.29K
Avg $ vol84.47M
SMA 20107.02
SMA 50102.36
SMA 20099.06
Price vs 50+12.85%
Price vs 200+16.62%
MA stackbullish
50/200 crossgolden · 9d
Supertrendup · 100.73
RSI (14)64
MACD hist0.85
MACD crossbull · 2d
Stoch %K / %D93 / 96
ADX (14)23
+DI / −DI28 / 14
RSI divergence—
MACD divergenceBullish
ATR %+4.21%
ADR %4.33%
52w high117.62
52w low75.82
From 52w high-1.79%
Above 52w low+52.36%
New 52w highNo
SqueezeOff
Bollinger width15.52%
%B1.01
Donchian pos93.20%
Donchian high116.83
Donchian low97.57
AVWAP (52w high)98.37
vs AVWAP high+17.43%
AVWAP (52w low)96.96
vs AVWAP low+19.15%
OBV trendUp
Chaikin MF (20)0.22
Today vs 20d2.91×
Avg vol (14d)863.41K
Avg vol (20d)781.29K
Avg $ vol (20d)84.47M
Market cap—
RS 3m (vs SPY)+14.46%
RS 6m (vs SPY)-2.79%
RS line new highNo
Trend template6/8
Technical rank79.5
1 week+12.40%
1 month+6.57%
3 months+22.67%
6 months+11.50%
1 year+24.91%
YTD+10.01%
P/E-40.52
P/B77.34
P/S41.97
P/FCF-68.29
EPS-3.11
Div yield—
ROE-190.85%
ROA-44.95%
Debt/Eq1.03
Current3.45
EV/EBITDA-41.80
Gross margin—
Net margin-103.57%
Rev growth45.83%
EPS growth24.58%
Price target142.40
Target upside23.10%
Analyst ratingBuy
Institutional116.86%
Ent. value8B
Revenue71.25M
Net income-49.3M
Gross profit—
Free cash flow-116.63M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out68.53M
Employees414
ListedThu, Oct 5, 2017
Free float—
Float %—
Short interest—
Days to cover—
Short volume—
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeA+
Conviction92 / 100
Pattern quality—
Tech rank79.5 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance113.82
Support99.30
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in RYTM
No recent disclosed trades by Congress in RYTM. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in RYTM · 10 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
JEAN CHRISTOPHE Director · Restricted Stock Units · 2026-06-24 | Grant | 2.32K | — | 2026-06-24 | 2026-06-25 |
Arbuckle Stuart A Director · Stock Option (right to buy) · 2026-06-24 | Grant | 3.69K | — | 2026-06-24 | 2026-06-25 |
GOOD JENNIFER L Director · Stock Option (right to buy) · 2026-06-24 | Grant | 3.69K | — | 2026-06-24 | 2026-06-25 |
MCGIRR DAVID W J Director · Stock Option (right to buy) · 2026-06-24 | Grant | 3.69K | — | 2026-06-24 | 2026-06-25 |
MCGIRR DAVID W J Director · Restricted Stock Units · 2026-06-24 | Grant | 2.32K | — | 2026-06-24 | 2026-06-25 |
TETRAULT LYNN A. Director · Stock Option (right to buy) · 2026-06-24 | Grant | 3.69K | — | 2026-06-24 | 2026-06-25 |
TETRAULT LYNN A. Director · Restricted Stock Units · 2026-06-24 | Grant | 2.32K | — | 2026-06-24 | 2026-06-25 |
Arbuckle Stuart A Director · Restricted Stock Units · 2026-06-24 | Grant | 2.32K | — | 2026-06-24 | 2026-06-25 |
GOOD JENNIFER L Director · Restricted Stock Units · 2026-06-24 | Grant | 2.32K | — | 2026-06-24 | 2026-06-25 |
JEAN CHRISTOPHE Director · Stock Option (right to buy) · 2026-06-24 | Grant | 3.69K | — | 2026-06-24 | 2026-06-25 |
SEC filings
EDGAR filings in RYTM · 5 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.